Linda Ji has extensive experience representing U.S. and international companies in connection with a wide range of domestic and cross-border corporate and commercial transactions, with a specialty focus on deals between China and the United States.  Linda represents clients ranging from startups to Fortune 500 companies in various industries, including emerging and high technologies, life sciences, consumer products, manufacturing and health care real estate.

Show More


  • Represent a selling shareholder in the process of the initial public offering (IPO) of Best, Inc. which raised $450 million.
  • Represent an international medical device company in connection with its proposed acquisition of the microsphere business (the high-value interventional oncology segment) from Boston Scientific valued at approximately $100M.
  • Represent a corporate venture fund in an investment in an early stage medical device company.

Show More


  • Chinese American Biotech Association (CABA)
  • New England Chinese Information and Network Association (NECINA)


St. Louis University School of Law, JD, magna cum laude
St. Louis University School of Law, LLM, magna cum laude
University of International Business and Economics School of Law, LLB, Outstanding Graduate Award

New York

Show More

Special Report / December 9, 2019

Shanghai, China / McDermott Event / December 5, 2018

Boston, Massachusetts / McDermott Event / June 6, 2018

Shanghai, China / McDermott Event / November 16, 2017